LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Kodu・Aktsiate loetelu・Novavax Inc

Novavax Inc

Suletud

SektorTervishoid

8.45 -5.69

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

8.43

Max

8.96

Põhinäitajad
By Trading Economics
Sissetulek	220M 18M
Müük	77M 147M
P/E Sektori keskmine	3.767 57.05
Aktsiakasum	0.11
Kasumimarginaal	11.912
Töötajad	749
EBITDA	220M 29M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+41.56% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	63M 1.6B
Eelmine avamishind	14.14
Eelmine sulgemishind	8.45

Uudiste sentiment

By Acuity

51%

49%

273 / 349 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

5.692 / 6.039 Toetus ja vastupanu

Novavax Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2025, 17:06 UTC

Suurimad hinnamuutused turgudel

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31. märts 2025, 14:19 UTC

Suurimad hinnamuutused turgudel

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

19. mai 2025, 14:30 UTC

Peamised uudised

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19. mai 2025, 13:27 UTC

Peamised uudised

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8. mai 2025, 17:55 UTC

Tulu

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8. mai 2025, 15:12 UTC

Tulu

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28. apr 2025, 17:04 UTC

Tulu

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Novavax Inc Prognoos

Hinnasiht

By TipRanks

41.56% tõus

12 kuu keskmine prognoos

Keskmine 12.67 USD 41.56%

Kõrge 19 USD

Madal 7 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Novavax Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Novavax Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

5.692 / 6.039Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Sentiment

By Acuity

273 / 349 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.